04/16/2024
3:12 PM | Teva Pharmaceutical Industries (Filer)
| Form ARS | |
04/16/2024
3:16 PM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A | |
04/09/2024
9:26 AM | Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A | |
03/07/2024
3:27 PM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:27 PM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:57 AM | Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:48 AM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/01/2024
5:52 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:54 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:40 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:43 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:45 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:37 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:42 AM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:37 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2024
6:49 AM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
7:03 AM | Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
02/01/2024
6:26 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:28 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:18 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:22 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
6:18 AM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:17 AM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/16/2023
6:35 AM | Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
6:36 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
6:15 AM | Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/05/2023
6:20 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
5:05 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
3:05 PM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
6:30 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:09 AM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2023
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
6:34 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:35 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:36 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:37 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:38 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/20/2023
6:39 AM | Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:31 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:32 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:33 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
11:32 AM | Capital Research Global Investors (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A | |
06/08/2023
7:30 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
